Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics experienced significant selling pressure from institutional entities, totaling over 1.5 million dollars recently. Conversely, company executives initiated multiple buy orders following the latest earnings report, which missed expectations. These transactions reflect divergent sentiment as the stock price remains near its annual low after a sharp ninety-day decline.
Ticker: CATX Exchange: ASE


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Perspective Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
224.52
Quantity 58,342 -23.8%
Value US$4,433,196
0.6
Morich Frank Non-Executive Director
Transaction date
Purchase
Price
314.96
Quantity 98,278 -32.2%
Value US$1,601,892
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
47.31
Quantity 91,707 -30.2%
Value US$1,508,006
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.84
Quantity 1,000 +188.7%
Value US$100,000
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
0.84
Quantity 1,000 +494.1%
Value US$100,000
0.6
Morich Frank Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 1,000 New position
Value US$100,000
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.84
Quantity 1,000 +24.4%
Value US$100,000
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.83
Quantity 1,000 +4.4%
Value US$100,000
3.6
Spoor Johan M. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.81
Quantity 1,000 +79.1%
Value US$100,000
3.7
Hunt Jonathan Robert Chief Accounting Officer Officer
Transaction date
Purchase
Price
2.03
Quantity 11,000 +22.5%
Value US$22,295
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
2.10
Quantity 9,498 +2595.1%
Value US$19,946
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
2.14
Quantity 38,145 +53.8%
Value US$81,775
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
2.13
Quantity 23,475 +14.7%
Value US$49,999
3.6
Spoor Johan M. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.21
Quantity 4,650 New position
Value US$10,288
3.6
Spoor Johan M. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.24
Quantity 22,026 +59.0%
Value US$49,384
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
2.27
Quantity 22,192 +45.6%
Value US$50,376
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Purchase
Price
2.25
Quantity 33,333 +1649.3%
Value US$74,946
0.6
HENSON HEIDI Non-Executive Director
Transaction date
Purchase
Price
3.85
Quantity 25,975 New position
Value US$100,004
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
3.77
Quantity 8,000 +28.3%
Value US$30,132
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
3.67
Quantity 2,619 +0.6%
Value US$9,612
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 3,647 +0.9%
Value US$13,202
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
3.88
Quantity 10,000 +25.8%
Value US$38,800
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
3.60
Quantity 2,400 +6.6%
Value US$8,640
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
3.94
Quantity 29 +0.1%
Value US$114
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
3.55
Quantity 400 +1.1%
Value US$1,420
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
3.80
Quantity 6,600 +11.0%
Value US$25,080
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
3.80
Quantity 5,400 New position
Value US$20,520
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
3.78
Quantity 14,500 +10.5%
Value US$54,868
3.4
Mark Austin affiliate
Transaction date
Proposed sale
Price
15.80
Quantity 2,500
Value US$39,500
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
9.82
Quantity 1,800 +5.3%
Value US$17,667
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
10.80
Quantity 83 +0.1%
Value US$896
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
10.90
Quantity 4,504 +2.9%
Value US$49,094
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
1.17
Quantity 100,000 +266.2%
Value US$117,430
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
1.46
Quantity 34,246 +2.3%
Value US$49,992
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
1.38
Quantity 55,000 +14.9%
Value US$75,900
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
1.40
Quantity 12,000 +3.6%
Value US$16,800
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
1.40
Quantity 13,006 +4.1%
Value US$18,207
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
1.34
Quantity 18,656 +5.3%
Value US$24,999
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
1.32
Quantity 11,375 +3.4%
Value US$15,015
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.70
Quantity 3,500 +1.0%
Value US$2,450
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.72
Quantity 42,879 +14.7%
Value US$30,873
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.71
Quantity 57,121 +24.3%
Value US$40,556
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.71
Quantity 5,127 +2.2%
Value US$3,640
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.71
Quantity 18,579 +8.8%
Value US$13,191
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.64
Quantity 21,235 +11.2%
Value US$13,590
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.64
Quantity 4,031 +2.2%
Value US$2,580
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.54
Quantity 50,000 +36.7%
Value US$27,000
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 25,000 +22.5%
Value US$13,750
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.59
Quantity 8,513 +8.3%
Value US$5,023
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.61
Quantity 14,850 +16.9%
Value US$9,058
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.61
Quantity 12,250 +16.2%
Value US$7,472
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.49
Quantity 22,134 +41.3%
Value US$10,846
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.50
Quantity 280,000 +25.6%
Value US$139,888
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.49
Quantity 29,862 +126.1%
Value US$14,632
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.33
Quantity 3,663 New position
Value US$1,203
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.34
Quantity 400,000 +57.5%
Value US$137,000
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.32
Quantity 13,680 +136.8%
Value US$4,378
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.26
Quantity 60,419 +9.5%
Value US$15,461
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.26
Quantity 10,000 New position
Value US$2,600
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.26
Quantity 125,000 +65.2%
Value US$32,338
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.27
Quantity 135,006 +27.0%
Value US$36,276
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
0.27
Quantity 152,962 +11.2%
Value US$41,284
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
0.27
Quantity 32,238 +2.4%
Value US$8,704
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.38
Quantity 32,200 +20.2%
Value US$12,236
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.38
Quantity 53,204 +50.0%
Value US$20,265
4.0
Woods Lori A CEO Executive Director
Transaction date
Purchase
Price
0.34
Quantity 100,000 +9.6%
Value US$33,540
3.4
Austin Mark John VP Finance/Prin Fin&Acct Offic Officer
Transaction date
Purchase
Price
0.29
Quantity 13,800 +34.3%
Value US$3,959
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-18 2026-11-17 B Purchase Non-Executive Director
58,342 -23.8%
224.52
US$4,433,196
58,342 -23.8% 224.52 US$4,433,196
2026-11-17 2026-11-16 B Purchase Non-Executive Director
98,278 -32.2%
314.96
US$1,601,892
98,278 -32.2% 314.96 US$1,601,892
2026-11-16 2026-11-12 B Purchase Non-Executive Director
91,707 -30.2%
47.31
US$1,508,006
91,707 -30.2% 47.31 US$1,508,006
2026-11-16 2026-11-12 B Purchase Non-Executive Director
1,000 +188.7%
0.84
US$100,000
1,000 +188.7% 0.84 US$100,000
2026-11-16 2026-11-12 B Purchase Non-Executive Director
1,000 +494.1%
0.84
US$100,000
1,000 +494.1% 0.84 US$100,000
2026-11-16 2026-11-12 B Purchase Non-Executive Director
1,000 New position
1.00
US$100,000
1,000 New position 1.00 US$100,000
2026-11-13 2026-11-12 B Purchase

Chief Medical Officer

Officer
1,000 +24.4%
0.84
US$100,000
1,000 +24.4% 0.84 US$100,000
2026-11-13 2026-11-11 B Purchase

Chief Medical Officer

Officer
1,000 +4.4%
0.83
US$100,000
1,000 +4.4% 0.83 US$100,000
2026-11-12 2026-11-11 B Purchase

Chief Executive Officer

Executive Director
1,000 +79.1%
0.81
US$100,000
1,000 +79.1% 0.81 US$100,000
2026-09-08 2026-09-04 S Sale Large shareholder
167,149 -1.5%
3.15
US$526,051
167,149 -1.5% 3.15 US$526,051
2026-09-08 2026-09-03 S Sale Large shareholder
80,783 -0.7%
3.11
US$250,896
80,783 -0.7% 3.11 US$250,896
2026-09-04 2026-09-02 S Sale Large shareholder
42,129 -0.4%
3.11
US$131,219
42,129 -0.4% 3.11 US$131,219
2026-09-04 2026-09-01 S Sale Large shareholder
35,769 -0.3%
3.12
US$111,574
35,769 -0.3% 3.12 US$111,574
2026-09-03 2026-09-01 S Sale Large shareholder
35,769 -0.3%
3.12
US$111,574
35,769 -0.3% 3.12 US$111,574
2026-09-04 2026-08-31 S Sale Large shareholder
78,145 -0.7%
3.14
US$245,610
78,145 -0.7% 3.14 US$245,610
2026-09-02 2026-08-31 S Sale Large shareholder
78,145 -0.7%
3.14
US$245,610
78,145 -0.7% 3.14 US$245,610
2025-11-17 2025-11-13 B Purchase

Chief Accounting Officer

Officer
11,000 +22.5%
2.03
US$22,295
11,000 +22.5% 2.03 US$22,295
2025-11-14 2025-11-12 B Purchase Non-Executive Director
9,498 +2595.1%
2.10
US$19,946
9,498 +2595.1% 2.10 US$19,946
2025-04-01 2025-03-31 B Purchase Non-Executive Director
38,145 +53.8%
2.14
US$81,775
38,145 +53.8% 2.14 US$81,775
2025-04-01 2025-03-31 B Purchase Non-Executive Director
23,475 +14.7%
2.13
US$49,999
23,475 +14.7% 2.13 US$49,999
2025-04-01 2025-03-28 B Purchase

Chief Executive Officer

Executive Director
4,650 New position
2.21
US$10,288
4,650 New position 2.21 US$10,288
2025-04-01 2025-03-28 B Purchase

Chief Executive Officer

Executive Director
22,026 +59.0%
2.24
US$49,384
22,026 +59.0% 2.24 US$49,384
2025-04-01 2025-03-28 B Purchase Non-Executive Director
22,192 +45.6%
2.27
US$50,376
22,192 +45.6% 2.27 US$50,376
2025-04-01 2025-03-28 B Purchase

Chief Financial Officer

Officer
33,333 +1649.3%
2.25
US$74,946
33,333 +1649.3% 2.25 US$74,946
2024-12-06 2024-12-04 B Purchase Non-Executive Director
25,975 New position
3.85
US$100,004
25,975 New position 3.85 US$100,004
2024-12-04 2024-12-04 B Purchase

CEO

Executive Director
8,000 +28.3%
3.77
US$30,132
8,000 +28.3% 3.77 US$30,132
2024-11-27 2024-11-25 B Purchase Non-Executive Director
2,619 +0.6%
3.67
US$9,612
2,619 +0.6% 3.67 US$9,612
2024-11-27 2024-11-25 B Purchase Non-Executive Director
3,647 +0.9%
3.62
US$13,202
3,647 +0.9% 3.62 US$13,202
2024-11-27 2024-11-25 B Purchase

Chief Financial Officer

Officer
10,000 +25.8%
3.88
US$38,800
10,000 +25.8% 3.88 US$38,800
2024-11-27 2024-11-25 B Purchase

Chief Financial Officer

Officer
2,400 +6.6%
3.60
US$8,640
2,400 +6.6% 3.60 US$8,640
2024-11-27 2024-11-25 B Purchase

Chief Financial Officer

Officer
29 +0.1%
3.94
US$114
29 +0.1% 3.94 US$114
2024-11-27 2024-11-25 B Purchase

Chief Financial Officer

Officer
400 +1.1%
3.55
US$1,420
400 +1.1% 3.55 US$1,420
2024-11-26 2024-11-25 B Purchase

CEO

Executive Director
6,600 +11.0%
3.80
US$25,080
6,600 +11.0% 3.80 US$25,080
2024-11-26 2024-11-25 B Purchase

CEO

Executive Director
5,400 New position
3.80
US$20,520
5,400 New position 3.80 US$20,520
2024-11-26 2024-11-25 B Purchase

CEO

Executive Director
14,500 +10.5%
3.78
US$54,868
14,500 +10.5% 3.78 US$54,868
2024-09-12 2024-09-12 PrS Proposed sale

affiliate

2,500
15.80
US$39,500
2,500 15.80 US$39,500
2024-06-18 2024-06-17 B Purchase

Chief Financial Officer

Officer
1,800 +5.3%
9.82
US$17,667
1,800 +5.3% 9.82 US$17,667
2024-06-18 2024-06-14 B Purchase Non-Executive Director
83 +0.1%
10.80
US$896
83 +0.1% 10.80 US$896
2024-06-18 2024-06-14 B Purchase Non-Executive Director
4,504 +2.9%
10.90
US$49,094
4,504 +2.9% 10.90 US$49,094
2024-06-13 2024-06-13 B Purchase

CEO

Executive Director
100,000 +266.2%
1.17
US$117,430
100,000 +266.2% 1.17 US$117,430
2024-06-04 2024-06-03 B Purchase Non-Executive Director
34,246 +2.3%
1.46
US$49,992
34,246 +2.3% 1.46 US$49,992
2024-06-03 2024-05-31 B Purchase Non-Executive Director
55,000 +14.9%
1.38
US$75,900
55,000 +14.9% 1.38 US$75,900
2024-06-03 2024-05-31 B Purchase

Chief Financial Officer

Officer
12,000 +3.6%
1.40
US$16,800
12,000 +3.6% 1.40 US$16,800
2024-06-03 2024-05-31 B Purchase

Chief Financial Officer

Officer
13,006 +4.1%
1.40
US$18,207
13,006 +4.1% 1.40 US$18,207
2024-05-30 2024-05-29 B Purchase Non-Executive Director
18,656 +5.3%
1.34
US$24,999
18,656 +5.3% 1.34 US$24,999
2024-05-30 2024-05-29 B Purchase Non-Executive Director
11,375 +3.4%
1.32
US$15,015
11,375 +3.4% 1.32 US$15,015
2024-03-08 2024-03-06 B Purchase Large shareholder
60,431,039 +107.3%
0.95
US$57,409,487
60,431,039 +107.3% 0.95 US$57,409,487
2024-02-01 2024-01-30 B Purchase Non-Executive Director
3,500 +1.0%
0.70
US$2,450
3,500 +1.0% 0.70 US$2,450
2024-02-01 2024-01-30 B Purchase Non-Executive Director
42,879 +14.7%
0.72
US$30,873
42,879 +14.7% 0.72 US$30,873
2024-02-01 2024-01-30 B Purchase Non-Executive Director
57,121 +24.3%
0.71
US$40,556
57,121 +24.3% 0.71 US$40,556
2024-02-01 2024-01-30 B Purchase Non-Executive Director
5,127 +2.2%
0.71
US$3,640
5,127 +2.2% 0.71 US$3,640
2024-02-01 2024-01-30 B Purchase Non-Executive Director
18,579 +8.8%
0.71
US$13,191
18,579 +8.8% 0.71 US$13,191
2024-01-30 2024-01-29 B Purchase Non-Executive Director
21,235 +11.2%
0.64
US$13,590
21,235 +11.2% 0.64 US$13,590
2024-01-30 2024-01-29 B Purchase Non-Executive Director
4,031 +2.2%
0.64
US$2,580
4,031 +2.2% 0.64 US$2,580
2024-01-30 2024-01-26 B Purchase Non-Executive Director
50,000 +36.7%
0.54
US$27,000
50,000 +36.7% 0.54 US$27,000
2024-01-30 2024-01-26 B Purchase Non-Executive Director
25,000 +22.5%
0.55
US$13,750
25,000 +22.5% 0.55 US$13,750
2024-01-30 2024-01-26 B Purchase Non-Executive Director
8,513 +8.3%
0.59
US$5,023
8,513 +8.3% 0.59 US$5,023
2024-01-30 2024-01-26 B Purchase Non-Executive Director
14,850 +16.9%
0.61
US$9,058
14,850 +16.9% 0.61 US$9,058
2024-01-30 2024-01-26 B Purchase Non-Executive Director
12,250 +16.2%
0.61
US$7,472
12,250 +16.2% 0.61 US$7,472
2024-01-26 2024-01-25 B Purchase Non-Executive Director
22,134 +41.3%
0.49
US$10,846
22,134 +41.3% 0.49 US$10,846
2024-01-26 2024-01-24 B Purchase

Chief Medical Officer

Officer
280,000 +25.6%
0.50
US$139,888
280,000 +25.6% 0.50 US$139,888
2024-01-26 2024-01-24 B Purchase Non-Executive Director
29,862 +126.1%
0.49
US$14,632
29,862 +126.1% 0.49 US$14,632
2023-12-26 2023-12-21 B Purchase Non-Executive Director
3,663 New position
0.33
US$1,203
3,663 New position 0.33 US$1,203
2023-12-19 2023-12-19 B Purchase

Chief Medical Officer

Officer
400,000 +57.5%
0.34
US$137,000
400,000 +57.5% 0.34 US$137,000
2023-12-19 2023-12-19 B Purchase Non-Executive Director
13,680 +136.8%
0.32
US$4,378
13,680 +136.8% 0.32 US$4,378
2023-12-19 2023-12-18 B Purchase

Chief Medical Officer

Officer
60,419 +9.5%
0.26
US$15,461
60,419 +9.5% 0.26 US$15,461
2023-12-19 2023-12-18 B Purchase Non-Executive Director
10,000 New position
0.26
US$2,600
10,000 New position 0.26 US$2,600
2023-12-19 2023-12-18 B Purchase

Chief Financial Officer

Officer
125,000 +65.2%
0.26
US$32,338
125,000 +65.2% 0.26 US$32,338
2023-12-19 2023-12-15 B Purchase

Chief Medical Officer

Officer
135,006 +27.0%
0.27
US$36,276
135,006 +27.0% 0.27 US$36,276
2023-12-18 2023-12-15 B Purchase Non-Executive Director
152,962 +11.2%
0.27
US$41,284
152,962 +11.2% 0.27 US$41,284
2023-12-18 2023-12-14 B Purchase Non-Executive Director
32,238 +2.4%
0.27
US$8,704
32,238 +2.4% 0.27 US$8,704
2022-12-05 2022-12-05 B Purchase

Chief Financial Officer

Officer
32,200 +20.2%
0.38
US$12,236
32,200 +20.2% 0.38 US$12,236
2022-12-05 2022-12-01 B Purchase

Chief Financial Officer

Officer
53,204 +50.0%
0.38
US$20,265
53,204 +50.0% 0.38 US$20,265
2022-11-17 2022-11-15 B Purchase

CEO

Executive Director
100,000 +9.6%
0.34
US$33,540
100,000 +9.6% 0.34 US$33,540
2022-06-09 2022-06-09 B Purchase

VP Finance/Prin Fin&Acct Offic

Officer
13,800 +34.3%
0.29
US$3,959
13,800 +34.3% 0.29 US$3,959

See older Perspective Therapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Perspective Therapeutics, Inc. history with Plus

Billed monthly · Cancel anytime